| Literature DB >> 30113391 |
Sander Rozemeijer1, Jelle L G Haitsma Mulier, Jantine G Röttgering, Paul W G Elbers, Angélique M E Spoelstra-de Man, Pieter Roel Tuinman, Monique C de Waard, Heleen M Oudemans-van Straaten.
Abstract
INTRODUCTION: Shock is characterized by micro- and macrovascular flow impairment contributing to acute kidney injury (AKI). Routine monitoring of the circulation regards the macrocirculation but not the renal circulation which can be assessed with Doppler ultrasound as renal resistive index (RRI). RRI reflects resistance to flow. High RRI predicts persistent AKI. Study aims were to determine whether RRI is elevated in shock and to identify determinants of RRI.Entities:
Mesh:
Year: 2019 PMID: 30113391 PMCID: PMC6587221 DOI: 10.1097/SHK.0000000000001246
Source DB: PubMed Journal: Shock ISSN: 1073-2322 Impact factor: 3.454
Fig. 1Flowchart of included patients. Inability to acquire adequate imaging was due to morbid obesity, wounds, immobility (after trauma), or agitation.
Baseline characteristics of the study population (n = 92)
| Patients with shock (n = 40) | Patients without shock (n = 52) | ||
| Age, y | 69 [60–76] | 67 [59–76] | 0.541 |
| Sex | 0.859 | ||
| Male, % | 67.5 | 69.2 | |
| Female, % | 32.5 | 30.8 | |
| BMI, kg/m2 | 25.2 ± 4.3 | 26.2 ± 4.3 | 0.280 |
| APACHE III | 87 [65–119] | 57 [45–69] | <0.001 |
| Lactate | 2.5 [1.4–4.3] | 1.2 [0.9–2.0] | <0.001 |
| Risk factors of AKI | |||
| Chronic kidney disease | 8 (20.0) | 8 (15.4) | 0.563 |
| Sepsis, n (%) | 6 (15.0) | 5 (9.6) | 0.430 |
| History of hypertension, n (%) | 12 (30.0) | 21 (40.4) | 0.303 |
| Diabetes, n (%) | 8 (20.0) | 9 (17.3) | 0.742 |
| Subgroups of admission | |||
| Elective surgical, n (%) | 18 (45.0) | 32 (61.5) | 0.114 |
| Emergency surgical, n (%) | 5 (12.5) | 3 (5.8) | 0.256 |
| Medical, n (%) | 17 (42.5) | 17 (32.7) | 0.334 |
| Renal function | |||
| Serum creatinine, μmol/L | 91 [76–122] | 75 [62–84] | <0.001 |
| Pre-admission eGFR, mL/min | 71 ± 15 | 76 ± 14 | 0.102 |
| Urinary indices | |||
| FENa | 0.4 [0.2–1.0] | 0.6 [0.3–1.5] | 0.314 |
| FEUrea | 31.9 [20.9–37.6] | 37.2 [27.6–44.9] | 0.024 |
| Albumin/creatinine ratio | 4.2 [1.2–11.4] | 2.8 [1.6–5.4] | 0.102 |
| Creatinine clearance | 52.3 [29.2–100.3] | 110.8 [79.5–149.6] | <0.001 |
| Hemodynamics | |||
| Heart rate (HR; bpm) | 87 [71–93] | 78 [70–88] | 0.209 |
| Mean arterial pressure (MAP; mmHg) | 70 [64–78] | 73 [66–86] | 0.171 |
| Pulse pressure index (PPI) | 0.456 ± 0.087 | 0.483 ± 0.074 | 0.121 |
| Central venous pressure | 10 [6–14] | 7 [4–10] | 0.007 |
| Cardiac index | 2.1 [1.8–2.3] | 2.1 [1.9–2.8] | 0.423 |
| SvO2 | 66 [61–75] | 68 [65–72] | 0.403 |
| Norepinephrine | 37 (92.5) | 5 (9.6) | <0.001 |
| Norepinephrine dose, μg/kg/min | 0.27 [0.14–0.44] | 0 [0.0–0.0] | <0.001 |
| Fluid balance | 3075 [1466–5025] | 528 [−79 to 938] | <0.001 |
BMI, body mass index; APACHE, acute physiology and chronic health evaluation; AKI, acute kidney injury; eGFR, estimated glomerular filtration rate; FENa, fractional excretion of sodium; FEUrea, fractional excretion of urea; SvO2, central or mixed venous oxygen saturation.
Data are presented as mean ± SD or as median with [interquartile range].
*Chronic kidney disease was defined as an eGFR before ICU admission of 30 to 60 mL/min; patients with eGFR <30 mL/min on admission were not included.
†n = 40 vs. n = 49.
‡n = 40 vs. n = 48.
§n = 39 vs. n = 50.
||Creatinine clearance (4-h portion), n = 40 vs. n = 51.
¶n = 33 vs. n = 35.
**n = 16 vs. n = 14.
††n = 31 vs. n = 35.
‡‡Norepinephrine support during the measurements.
§§Fluid balance from ICU admission until measurements (<24-h after admission).
Fig. 2Renal resistive index of patients admitted with shock (n = 40) and without shock (n = 52).
Study parameters
| Patients with shock | Patients without shock | ||
| Renal resistive index (RRI) | |||
| Left kidney | 0.757 [0.690–0.792] | 0.656 [0.596–0.696] | <0.001 |
| Right kidney | 0.746 [0.693–0.786] | 0.656 [0.621–0.690] | <0.001 |
| Overall | 0.751 [0.692–0.788] | 0.654 [0.610–0.686] | <0.001 |
| Microcirculation (SDF) | |||
| Vessel density (VD; n/mm) | 9.5 ± 1.6 | 9.7 ± 2.6 | 0.698 |
| Perfused vessel density (PVD; n/mm) | 7.0 ± 1.4 | 7.1 ± 2.1 | 0.747 |
| Percentage of perfused vessels (PPV; %) | 73.9 ± 12.1 | 73.1 ± 14.0 | 0.817 |
| Microvascular flow index (MFI) | 2.0 ± 0.5 | 2.0 ± 0.5 | 0.926 |
| Bioelectral impedance analysis (BIA) | |||
| Resistance (R/m) | 285.0 [245.9–324.9] | 285.1 [255.1–326.6] | 0.585 |
| Reactance (Xc/m) | 22.1 [17.4–29.2] | 24.3 [21.6–29.8] | 0.075 |
| Phase angle | 4.3 [3.3–5.4] | 4.9 [4.0–6.1] | 0.066 |
SDF, sidestream dark field.
Data are presented as mean ± SD or as median with [interquartile range].
*n = 40 vs. n = 52.
†n = 32 vs. n = 36.
‡No flow [0], intermittent flow [1], slow/sluggish flow [2], and continuous flow [3].
§n = 39 vs. n = 50.
Renal resistive index in different subgroups
| No. of patients | Renal resistive index | ||
| Shock vs. nonshock | n = 40 vs. n = 52 | 0.751 [0.692–0.788] vs. 0.654 [0.610–0.686] | <0.001 |
| Lactate ≥3 vs. <3 mmol/L | n = 22 vs. n = 70 | 0.720 [0.673–0.779] vs. 0.672 [0.626–0.735] | 0.034 |
| Lactate ≥3 mmol/L + VP support vs. other | n = 16 vs. n = 76 | 0.751 [0.687–0.781] vs. 0.674 [0.626–0.734] | 0.016 |
VP, vasopressor.
Data are presented as median with [interquartile range].
*According to the clinical criteria as described above.
Univariable regression analysis
| Variable | n | Regression coefficient | 95% CI | SE of | Correlation coefficient | |
| Systemic circulation | ||||||
| Heart rate (HR; bpm) | 92 | 0.000 | −0.001–0.001 | 0.001 | −0.07 | 0.535 |
| Mean arterial pressure (MAP; mmHg) | 92 | −0.002 | −0.004–−0.001 | 0.001 | −0.30 | 0.004 |
| Pulse pressure index (PPI) | 92 | 0.367 | 0.167–0.567 | 0.101 | 0.36 | <0.001 |
| Central venous pressure (CVP; cmH2O) | 68 | 0.009 | 0.005–0.013 | 0.002 | 0.50 | <0.001 |
| Cardiac index (CI) | 30 | −0.033 | −0.111–0.045 | 0.038 | −0.16 | 0.395 |
| Venous oxygen saturation (SvO2; %) | 66 | 0.001 | −0.001–0.004 | 0.001 | 0.12 | 0.354 |
| Vasopressor support | 92 | 0.083 | 0.054–0.113 | 0.015 | 0.51 | <0.001 |
| Norepinephrine dose, μg/kg/min | 92 | 0.144 | 0.072–0.216 | 0.036 | 0.39 | <0.001 |
| Microcirculation | ||||||
| Vessel density (VD; n/mm) | 68 | −0.004 | −0.014–0.005 | 0.005 | −0.11 | 0.370 |
| Perfused vessel density (PVD; n/mm) | 68 | −0.008 | −0.019–0.003 | 0.005 | −0.12 | 0.149 |
| Percentage of perfused vessels (PPV; %) | 68 | −0.001 | −0.002–0.001 | 0.001 | −0.13 | 0.300 |
| Microvascular flow index (MFI) | 68 | −0.032 | −0.070–0.005 | 0.019 | −0.21 | 0.092 |
| Hydration | ||||||
| Fluid balance, L | 92 | 0.011 | 0.005–0.017 | 0.003 | 0.34 | 0.001 |
| Resistance (R/m) | 89 | 0.000 | 0.000–0.000 | 0.000 | −0.12 | 0.281 |
| Reactance (Xc/m) | 89 | −0.003 | −0.005–−0.001 | 0.001 | −0.34 | 0.001 |
| Phase angle | 89 | −0.011 | −0.021–−0.001 | 0.005 | −0.23 | 0.031 |
| Concomitant renal function | ||||||
| Creatinine clearance, mL/min | 91 | −0.001 | −0.001–0.000 | 0.000 | −0.42 | <0.001 |
| FEUrea, % | 88 | −0.002 | −0.003–0.000 | 0.001 | −0.24 | 0.022 |
| FENa, % | 89 | −0.015 | −0.030–0.001 | 0.008 | −0.20 | 0.067 |
| Albumin/creatinine ratio | 89 | 0.000 | −0.001–0.000 | 0.000 | −0.05 | 0.637 |
| Other | ||||||
| Age, y | 92 | 0.002 | 0.001–0.003 | 0.001 | 0.30 | 0.004 |
| APACHE III | 92 | 0.001 | 0.000–0.001 | 0.000 | 0.37 | <0.001 |
| Lactate, mmol/L | 92 | 0.015 | 0.004–0.025 | 0.005 | 0.28 | 0.006 |
| Preadmission eGFR, mL/min | 92 | −0.002 | −0.003–−0.001 | 0.001 | −0.30 | 0.004 |
| BMI, kg/m2 | 92 | 0.000 | −0.004–0.004 | 0.002 | −0.02 | 0.834 |
SE, standard error; FEUrea, fractional excretion of urea; FENa, fractional excretion of sodium; APACHE, acute physiology and chronic health evaluation; eGFR, estimated glomerular filtration rate; BMI, body mass index.
*If X increases with 1, RRI increases with B. Variable = X.
†Central or mixed venous oxygen saturation.
‡0 = no vasopressor support; 1 = vasopressor support.
§Fluid balance from ICU admission until measurements (<24-h after admission).
||Creatinine clearance (4-h portion).
Multivariable regression analysis
| Final model | ||||
| Regression coefficient | 95% CI | SE of | ||
| 0.601 | 0.476–0.726 | 0.064 | <0.001 | |
| Systemic circulation | ||||
| Vasopressor support | 0.059 | 0.035–0.084 | 0.012 | <0.001 |
| Central venous pressure (CVP; cmH2O) | 0.006 | 0.003–0.009 | 0.002 | <0.001 |
| Pulse pressure index (PPI) | 0.418 | 0.275–0.561 | 0.073 | <0.001 |
| Mean arterial pressure (MAP; mmHg) | −0.001 | −0.002–0.000 | 0.001 | 0.006 |
| Membrane capacitance | ||||
| Reactance (Xc/m) | −0.001 | −0.003–0.000 | 0.001 | 0.045 |
| Renal function | ||||
| Pre-admission eGFR, mL/min | −0.001 | −0.002–0.000 | 0.000 | 0.097 |
RRI = 0.601 + vasopressor support × 0.059 + CVP × 0.006 + PPI × 0.418 – MAP × 0.001 – reactance/m × 0.001 – preadmission eGFR × 0.001.
*0 = no vasopressor support; 1 = vasopressor support.
Sample size = 92; mean adjusted R2 = 0.587 [minimum 0.552 − maximum 0.638]; mean standard error of estimate = 0.053.
SE indicates standard error.